Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid pressure from rival Eli Lilly.Read More
You might also be interested in reading South Korea’s president heads into Trump talks on troops, trade and Pyongyang.
